A phase II study of hypofractionated proton therapy for prostate cancer.Published in:Acta Oncologica, 2013, v. 52, n. 3, p. 477, doi. 10.3109/0284186X.2013.764011By:Kim, Yeon-Joo;Cho, Kwan Ho;Pyo, Hong Ryull;Lee, Kang Hyun;Moon, Sung Ho;Kim, Tae Hyun;Shin, Kyung Hwan;Kim, Joo-Young;Lee, Se Byeong;Nam, Byong HoPublication type:Article